Journal of International Oncology››2014,Vol. 41››Issue (2): 150-154.doi:10.3760/cma.j.issn.1673-422X.2014.02.021
Previous ArticlesNext Articles
Wang Yuling, Yu Enda, Qian Wei, Yang Fan, Zhu Wei, Zhang Yongzheng, Li Zhaoshen, Cai Quancai
Received:
2013-06-04Revised:
2013-12-20Online:
2014-02-08Published:
2014-01-26Contact:
Cai Quancai E-mail:qccai1026@gmail.comWang Yuling, Yu Enda, Qian Wei, Yang Fan, Zhu Wei, Zhang Yongzheng, Li Zhaoshen, Cai Quancai. Risk of colorectal tumor after negative baseline screening colonoscopy[J]. Journal of International Oncology, 2014, 41(2): 150-154.
[1] Jemal A, Bray F, Center MM, et al. Global cancer statistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90. [2] Nelson RS, Thorson AG. Colorectal cancer screening[J]. Curr Oncol Rep, 2009, 11(6): 482-489. [3] Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012[J]. CA Cancer J Clin, 2012, 62(1): 10-29. [4] 郑树. 结直肠癌的预防[J]. 中华肿瘤防治杂志, 2006, 13(1): 1-2. [5] Davila RE, Rajan E, Baron TH, et al. ASGE guideline: colorectal cancer screening and surveillance[J]. Gastrointest Endosc, 2006, 63(4): 546-557. [6] Rex DK, Johnson DA, Anderson JC, et al. American college of gastroenterology guidelines for colorectal cancer screening 2009[J]. Am J Gastroenterol, 2009, 104(3): 739-750. [7] 刘国伟, 蔡全才. 无症状平均风险人群大肠癌的筛查[J]. 世界华人消化杂志, 2009, 17(28): 2958-2963. [8] Cai QC, Yu ED, Xiao Y, et al. Derivation and validation of a prediction rule for estimating advanced colorectal neoplasm risk in average risk Chinese[J]. Am J Epidemiol, 2012, 175(6): 584-593. [9] Choe JW, Chang HS, Yang SK, et al. Screening colonoscopy in asymptomatic averagerisk Koreans: analysis in relation to age and sex[J]. J Gastroenterol Hepatol, 2007, 22(7): 1003-1008. [10] Leung WK, Lau JY, Suen BY, et al. Repeatscreening colonoscopy 5 years after normal baselinescreening colonoscopy in averagerisk Chinese: a prospective study[J]. Am J Gastroenterol, 2009, 104(8): 2028-2034. [11] Lieberman DA, Weiss DG, Harford WV, et al. Fiveyear colon surveillance after screening colonoscopy[J]. Gastroenterology, 133(4): 1077-1085. [12] Pinsky PF, Schoen RE, Weissfeld JL, et al. The yield of surveillance colonoscopy by adenoma history and time to examination[J]. Clin Gastroenterol Hepatol, 2009, 7(1): 86-92. [13] Chung SJ, Kim YS, Yang SY, et al. Fiveyear risk for advanced colorectal neoplasia after initial colonoscopy according to the baseline risk stratification: a prosp ective study in 2452 asymptomatic Koreans[J]. Gut, 2011, 60(11): 1537-1543. [14] Huang Y, Gong W, Su B, et al. Recurrence and surveillance of colorectal adenoma after polypectomy in a southern Chinese population[J]. J Gastroenterol, 2010, 45(8): 838-845. [15] 梁荣, 于恩达, 朱伟, 等. 大肠癌平均风险人群进展期肿瘤的年龄分布分析[J]. 第二军医大学学报, 2012, 33(4): 368-373. |
[1] | Zhang Rui, Chu Yanliu.Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota[J]. Journal of International Oncology, 2024, 51(6): 370-375. |
[2] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[3] | Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao.Effect of cancer nodules on liver metastases after radical resection of colorectal cancer[J]. Journal of International Oncology, 2024, 51(5): 280-285. |
[4] | Sun Guobao, Yang Qian, Zhuang Qingchun, Gao Binbin, Sun Xiaogang, Song Wei, Sha Dan.Research progress on the histopathological growth patterns of colorectal liver metastasis[J]. Journal of International Oncology, 2024, 51(2): 114-118. |
[5] | Liu Debao, Sun Ziwen, Lu Shoutang, Xu Haidong.Expression and clinical significance of ASB6 in colorectal cancer tissues[J]. Journal of International Oncology, 2023, 50(8): 470-474. |
[6] | Chen Zhuo, Tao Jun, Chen Lin, Ke Jing.Value of detection of peripheral blood miR-194 combined with fecal miR-143 in the clinical screening of colorectal cancer[J]. Journal of International Oncology, 2023, 50(5): 268-273. |
[7] | Huang Zhen, Zhang Caiyutian, Ke Shaobo, Shi Wei, Zhao Wensi, Chen Yongshun.Construction of postoperative prognosis model for patients with colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 157-163. |
[8] | Xu Liangfu, Li Yuanfei.Research progress on tumor microenvironment and immune combination therapy of MSS colorectal cancer[J]. Journal of International Oncology, 2023, 50(3): 186-190. |
[9] | Liu Yujie, Zhao Zhiqiang, Wang Zicheng.Levels and diagnostic value of TOP2A and ERBB2 in peripheral blood mononuclear cells of patients with early colorectal cancer[J]. Journal of International Oncology, 2023, 50(12): 717-722. |
[10] | Tao Hong, Yin Hong, Luo Hong, Tao Jiayu.Potential strategies for targeting tumor-associated macrophages to enhance the efficacy of immune checkpoint inhibitors for colorectal cancer[J]. Journal of International Oncology, 2023, 50(11): 683-687. |
[11] | Wang Xi, Wu Chuanqing.Research progress in reversing multidrug resistance in colorectal cancer[J]. Journal of International Oncology, 2023, 50(1): 42-46. |
[12] | Gao Yizhao, Liu Yang, Liu Qiulong, Xing Jinliang.Application of circulating cell-free nucleic acid in clinical diagnosis and treatment of colorectal cancer[J]. Journal of International Oncology, 2022, 49(9): 555-559. |
[13] | He Zhefeng, Wu Yiyang, Li Zhenjun, Ying Xiaojiang.Predictive value of inflammatory markers in colorectal cancer[J]. Journal of International Oncology, 2022, 49(9): 560-563. |
[14] | Zhao Ying, Zhang Gehong.Study on the correlations between AGR, PLR and NLR changes and chemotherapy efficacy of metastatic colorectal cancer[J]. Journal of International Oncology, 2022, 49(8): 473-477. |
[15] | Huang Mengpan, Wang Xuehong, Lu Yongfu.Mechanism of FOXA2 in colorectal cancer and its application in diagnosis and treatment[J]. Journal of International Oncology, 2022, 49(8): 490-493. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||